Journal Reading

Local and Regional Anesthesia

Pembimbing :Dr.Robert Sirait, SpAn

Disusun Oleh :I Gede Bungas Arisudana

1061050067

KEPANITERAAN ANESTESI FAKULTAS KEDOKTERAN UNIVERSITAS KRISTEN

INDONESIA PERIODE 27 JULI – 29 AGUSTUS 2015

JAKARTA

Local and Regional AnesthesiaAuthor: Robyn Gmyrek, MD; Chief Editor: Dirk M Elston, MD

OverviewLocal anesthetics provide a reversible regional loss of sensation. Local anesthetics reduce pain, thereby facilitating surgical procedures. Delivery techniques broaden the clinical applicability of local anesthetics. These techniques include topical anesthesia, infiltrative anesthesia, ring blocks, and peripheral nerve blocks (see the Technique section below for links to detailed, illustrated articles demonstrating these techniques).

Local anesthetics are safer than general or systemic anesthetics; therefore, they are used whenever possible. In addition, they are relatively easy to administer and readily available. Local anesthetics have been undergoing development for centuries, and, as this article illustrates, research continues to provide surgeons with pharmacologic variety and to provide patients with anesthetic agents that have superior safety and efficacy profiles.

Background

Although the medical world cannot cure every disease, the control of pain to ensure patient comfort should be a goal. In 1860, cocaine, the oldest anesthetic, was extracted from the leaves of theErythroxylon coca bush. In 1884, Sigmund Freud and Karl Koller were the first to use it as an anesthetic agent during ophthalmologic procedures.

Procaine, a synthetic alternative to cocaine, was not developed until 1904. Procaine is an ester of para-aminobenzoic acid (PABA). As procaine is metabolized, PABA, a known allergen, is released as a metabolic product. The potential for severe allergic reactions limits the use of procaine and other ester-type anesthetic agents. Tetracaine, another ester-type anesthetic, was introduced in 1930. Tetracaine is more potent than procaine, and it causes similar allergic reactions.

In 1943, an alternative class of anesthetics was discovered when Lofgren developed lidocaine. This agent is an amide derivative of diethylaminoacetic acid, not PABA; therefore, it has the benefit of a low allergic potential. Since then, multiple amide-type anesthetics have been introduced into clinical use. Slight chemical alterations to the compounds have imparted beneficial characteristics, including increased duration and potency, to each. These compounds offer the surgeon more choices, and anesthetics can be appropriately matched to different procedures.

Pathophysiology

Reviewing the physiology of nerve conduction is important before any discussion of local anesthetics. Nerves transmit sensation as a result of the propagation of electrical impulses; this propagation is accomplished by alternating the ion gradient across the nerve cell wall, or axolemma.

In the normal resting state, the nerve has a negative membrane potential of -70 mV. This resting potential is determined by the concentration gradients of 2 major ions, Na+ and K+, and the relative membrane permeability to these ions (also known as leak currents). The concentration

gradients are maintained by the sodium/potassium ATP pump (in an energy-dependent process) that transports sodium ions out of the cell and potassium ions into the cell. This active transport creates a concentration gradient that favors the extracellular diffusion of potassium ions. In addition, because the nerve membrane is permeable to potassium ions and impermeable to sodium ions, 95% of the ionic leak in excitable cells is caused by K+ ions in the form of an outward flux, accounting for the negative resting potential. The recently identified 2-pore domain potassium (K2P) channels are believed to be responsible for leak K+ currents.

When a nerve is stimulated, depolarization of the nerve occurs, and impulse propagation progresses. Initially, sodium ions gradually enter the cell through the nerve cell membrane. The entry of sodium ions causes the transmembrane electric potential to increase from the resting potential. Once the potential reaches a threshold level of approximately -55 mV, a rapid influx of sodium ions ensues. Sodium channels in the membrane become activated, and sodium ion permeability increases; the nerve membrane is depolarized to a level of +35 mV or more.

Once membrane depolarization is complete, the membrane becomes impermeable to sodium ions again, and the conductance of potassium ions into the cell increases. The process restores the excess of intracellular potassium and extracellular sodium and reinstates the negative resting membrane potential. Alterations in the nerve cell membrane potential are termed the action potential. Leak currents are present through all the phases of the action potential, including setting of the resting membrane potential and repolarization.

Mechanism of action

Local anesthetics inhibit depolarization of the nerve membrane by interfering with both Na+ and K+ currents. The action potential is not propagated because the threshold level is never attained.

Although the exact mechanism by which local anesthetics retard the influx of sodium ions into the cell is unknown, 2 theories have been proposed. The membrane expansion theory postulates that the local anesthetic is absorbed into the cell membrane, expanding the membrane and leading to narrowing of the sodium channels. This hypothesis has largely given way to the specific receptor theory. This theory proposes that the local anesthetic diffuses across the cell membrane and binds to a specific receptor at the opening of the voltage-gated sodium channel. The local anesthetic affinity to the voltage-gated Na+ channel increases markedly with the excitation rate of the neuron. This binding leads to alterations in the structure or function of the channel and inhibits sodium ion movement. Blockade of leak K+ currents by local anesthetics is now also believed to contribute to conduction block by reducing the ability of the channels to set the membrane potential.

On the basis of their diameter, nerve fibers are categorized into 3 types. Type A fibers are the largest and are responsible for conducting pressure and motor sensations. Type B fibers are myelinated and moderate in size. Type C fibers, which transmit pain and temperature sensations, are small and unmyelinated. As a result, anesthetics block type C fibers more easily than they do type A fibers. Therefore, patients who have blocked pain sensation still feel pressure and have mobility because of the unblocked type A fibers.

All local anesthetics have a similar chemical structure, which consists of 3 components: an aromatic portion, an intermediate chain, and an amine group (see molecular diagram below). The aromatic portion, usually composed of a benzene ring, is lipophilic, whereas the amine portion of

the anesthetic is responsible for its hydrophilic properties. The degree of lipid solubility of each anesthetic is an important property because its lipid solubility enables its diffusion through the highly lipophilic nerve membrane. The extent of an anesthetic's lipophilicity is directly related to its potency.

Molecular diagram.Local anesthetics are weak bases that require the addition of hydrochloride salt to be water soluble and therefore injectable. Salt equilibrates between an ionized form and a non ionized form in aqueous solution. Equilibration is crucial because, although the ionized form is injectable, the nonionized base has the lipophilic properties responsible for its diffusion into the nerve cell membrane. The duration of action of an anesthetic or the period during which it remains effective is determined by its protein-binding activity, because the anesthetic receptors along the nerve cell membrane are proteins.

The intermediate chain, which connects the aromatic and amine portions, is composed of either an ester or an amide linkage (see molecular diagram above). This intermediate chain can be used in classifying local anesthetics.

Indications

Anesthesia is indicated to reduce pain before surgical procedures.

Contraindications

Patient allergies may preclude the use of a particular anesthetic agent (see Complications section below).

Anesthesia

Local anesthetics are classified into 2 groups: the ester group and the amide group. The classification is based on the chemical structure of the intermediate chain. This structural difference affects the pathway by which local anesthetics are metabolized and the allergic potential.

Ester anesthetics are listed in the Table below. They are metabolized by hydrolysis, which depends on the plasma enzyme pseudocholinesterase. Some patients have a rare genetic defect in the structure of this enzyme and may be unable to metabolize ester-type anesthetics; this inability increases the possibility of their having toxic reactions and elevated levels of anesthetics in the blood. In addition, 1 of the metabolic products generated by hydrolysis is PABA, which inhibits the action of sulfonamides and is a known allergen. In patients with a known allergy to an ester anesthetic, the use of all other ester-type anesthetic agents should be avoided.

Amide-type local anesthetics (see Table below) are metabolized by microsomal enzymes located in the liver. The specific microsomal enzyme responsible for the elimination of lidocaine is cytochrome P-450 3A4. Therefore, amide-type anesthetics should be used with care in patients with severe liver disease and patients taking medications that interfere with the metabolism of the anesthetic, and the patients should be carefully monitored for signs of toxicity.

Cytochrome P-4503A4 is present in the small bowel and the liver. Commonly used medications known to inhibit cytochrome P-4503A4 are listed below (adapted from Klein and Kassarjdian).[1] Specific potent inhibitors of cytochrome P-4503A4 that have been associated with clinically relevant interactions include itraconazole, ketoconazole (azole antifungals), erythromycin, clarithromycin, cyclosporin (macrolides), amprenavir, indinavir, nelfinavir, ritonavir (HIV protease inhibitors), diltiazem, mibefradil (calcium channel blockers), and nefazodone. Grapefruit juice is also a potent inhibitor of P-4503A4 but appears to affect only the enteric enzyme, which does not play a role in the metabolism of local anesthetics.

If the enzyme is inhibited because of the concurrent use of medications, it is unavailable to metabolize the anesthetic and potentially toxic levels of the anesthetic can occur. In addition, beta-blockers may decrease blood flow to the liver; therefore, they may also decrease the metabolism of amide-type anesthetics and may cause serum levels of the anesthetic to increase.

Table. Common Local Anesthetics* (Open Table in a new window)

Anesthetic

Duration Without Epinephrine,

min 

Duration With Epinephrine,

min 

Maximum Dose Without Epinephrine,

mg/kg 

Maximum Dose With Epinephrine,

mg/kg 

Esters

Cocaine 45 - 2.8 -

Procaine 15-30 30-90 7.1 8.5

Chloroprocaine

30-60 - 11.4 14.2

Tetracaine 120-240 240-480 1.4 -

Amides

Lidocaine 30-120 60-400 4.5 7

Mepivacaine 30-120 30-120 4.5 7

Bupivacaine 120-240 240-480 2.5 3.2

Etidocaine 200 240-360 4.2 5.7

Prilocaine 30-120 60-400 5.7 8.5

*Adapted from Dinehart.[2]

Technique

Specific local anesthetic techniques are described in detail in the following eMedicine topics:

Anesthesia, Regional, Digital Block Anesthesia, Topical Local Anesthetic Agents, Infiltrative Administration Nerve Block, Deep Peroneal Nerve Block, Dorsal Penile Nerve Block, Dorsal Penile, Neonatal Nerve Block, Inferior Alveolar Nerve Block, Infraorbital Nerve Block, Oral Nerve Block, Median Nerve Block, Mental Nerve Block, Posterior Tibial Nerve Block, Radial Nerve Block, Saphenous Nerve Block, Superficial Peroneal Nerve Block, Supraorbital Nerve Block, Sural

Complications

Local effects

Local effects are usually a result of the injection technique. These effects include pain, ecchymosis, hematoma formation, infection, and nerve laceration. Pain is always felt when a local anesthetic is injected; however, associated discomfort can be minimized by using good technique. Several factors, including needle puncture of the skin, tissue irritation resulting from the anesthetic, and distention of tissues caused by infiltration, are responsible for the discomfort associated with the use of local anesthetics.

Pediatric patients and patients who are extremely anxious may benefit from pretreatment of the injection area with a topical anesthetic.[3] Pretreatment eliminates the initial pain that occurs when the needle perforates the skin. Small-diameter needles also decrease the pain associated with injection. Fortunately, for most dermatologic procedures, a 30-gauge needle can be used to infiltrate tissue.

Tissue irritation caused by local anesthetics is related to the acidity of the infiltrated solution; therefore, increasing the pH of the mixture can decrease associated discomfort. The addition of epinephrine to an anesthetic solution decreases the pH of the solution, making it more acidic (pH 3.5-4.5) and leading to a more painful injection. The solution can be neutralized by the addition of sodium bicarbonate 8.4% to minimize discomfort. For example, sodium bicarbonate 8.4% can be added to lidocaine with epinephrine in a 1:10 ratio to achieve a solution pH similar to that of tissue fluid (pH 7.3-7.4).

Discomfort associated with distension of the tissues during the injection of local anesthetics is caused by the rate of injection and the volume of fluid injected. To limit the pain, the anesthetic should be slowly administered to allow the stretch receptors time to accommodate the new volume of fluid.[4] In addition, the volume of solution injected should be the smallest volume needed to achieve a loss of sensation at the surgical site.

Studies have shown that patients receiving subcutaneous or intradermal injection of local anesthetics that were warmed to body temperature, as opposed to room temperature, experienced less pain during injection. If possible, warming of local anesthetics should be done prior to administration.[5]

The formation of ecchymosis or a local hematoma is a result of the perforation of cutaneous blood vessels. These complications are encountered more commonly in areas of high vascularity, including the mucous membranes, head, and genitalia. Ecchymosis and hematoma are even more pronounced when the patient has a bleeding diathesis or when the patient has been taking aspirin or other anticoagulants. If ecchymosis occurs, the patient should simply be reassured. If hematoma formation occurs, the patient should be evaluated. The hematoma may require drainage with an 18-gauge needle, followed by the application of a pressure dressing.

Infection is an additional local complication of anesthetic use that usually occurs when proper sterile technique is not used. Cleansing the skin surface with alcohol is adequate in otherwise clean or noninfected areas. If signs of infection are noted, treatment includes appropriate culture studies and antimicrobial therapy. If abscess formation occurs, drainage may also be required.

Nerve laceration, although rare, may occur during the infiltration of a local anesthetic. This complication more commonly occurs during the placement of regional blocks than the placement of other blocks. Clinical indications of nerve laceration include paresthesias, shooting or sharp stinging sensations, and excessive pain during needle insertion. Paresthesias of the infraorbital nerve are characterized by sharp or shooting sensations involving the upper lip, nasal ala, and upper teeth.

If the needle is suspected to have entered or lacerated a nerve, it should be withdrawn slowly and deliberately by 1-2 mm, until the paresthesias are no longer present. The needle should never be advanced further, moved laterally, or inserted into the foramen, because these maneuvers further

increase the risk of nerve laceration. Although dysesthesias may remain for an extended duration, in most patients, the nerve regenerates and sensation normalizes over time.

Tendon injury is an inherent aspect of transthecal digital anesthesia since the needle is pushed through the tendon. This may cause persistent discomfort lasting 1-2 days post surgery. Tendon sheath infection and late occurrence of trigger finger have also been reported.

Cutaneous adverse effects that have been reported with the most commonly used topical anesthetic EMLA include itching, burning, pain, pallor, erythema, edema, and purpura. Irritant dermatitis, allergic contact dermatitis, and contact urticaria have also been reported, but these are very unusual.[6]

Amethocaine may induce an urticarial reaction at the site of application, and the risk of such a reaction seems to be significantly higher when amethocaine is used over the antecubital fossa and in younger children.

Systemic effects

Systemic effects usually occur when blood concentrations of local anesthetic increase to toxic levels.[7] Effects are most often encountered after the unintentional intravenous injection or administration of an excessive dose of an anesthetic. Adding a vasoconstrictor (eg, epinephrine) can reduce the systemic absorption of an anesthetic. When using topical anesthetics, strict adherence to the maximal dose or area recommended is advised; additionally, great caution must be exercised when using topical anesthetics on mucosal surfaces because of the much greater absorption.

Importantly, remember that (1) the metabolism of ester anesthetics is decreased in patients with deficient pseudocholinesterase activity and (2) the metabolism of amide anesthetics in patients who are taking medications that inhibit the cytochrome P-450 system is decreased. In addition, the potency of an anesthetic is directly correlated with the potential for toxicity. Allergic reactions, although systemic, are not related to serum levels of the anesthetic, but rather, they are considered idiosyncratic and can occur at any dose.

Maximal safe doses of lidocaine for local anesthesia have been determined. For adults, a maximum of 4.5 mg of lidocaine per kilogram of body weight can be administered, whereas as much as 7 mg/kg can be used if the lidocaine solution has 1:100,000 epinephrine added as a vasoconstrictor. For children, lower maximal doses are recommended; only 1.5-2.5 mg/kg of plain lidocaine and 3-4 mg/kg of lidocaine with epinephrine should be used.

Systemic toxicity resulting from excessive blood levels of anesthetics is clinically manifested as adverse reactions in the CNS and cardiovascular system. The CNS is affected in a predictable and dose-dependent fashion. As serum levels of lidocaine increase, effects on the CNS become more severe.

Any physician who uses local anesthetics must be aware of the signs and symptoms of systemic toxicity. At serum lidocaine levels in the range of 1-5 mcg/mL, patients may complain of tinnitus, lightheadedness, circumoral numbness, diplopia, or a metallic taste in the mouth. In addition, they may complain of nausea and/or vomiting, or they may become more talkative. As

serum levels increase to 5-8 mcg/mL, nystagmus, slurred speech, localized muscle twitching, or fine tremors may be noticed. Patients also have been noted to have hallucinations at these levels. If blood lidocaine levels reach 8-12 mcg/mL, focal seizure activity occurs; this can progress to generalized tonic-clonic seizures. Respiratory depression occurs at extremely high blood levels (20-25 mcg/mL) and can progress to coma.

If signs of CNS toxicity are noted, steps must be taken to reduce hypoxia and acidosis, because these states increase the toxicity of local anesthetics. The patient's airway should be maintained, and supplemental oxygen provided. If blood levels of carbon dioxide increase, protein binding of lidocaine decreases and results in higher levels of free lidocaine in the blood. Increased respiration and respiratory alkalosis increase the seizure threshold and decrease the uptake of the local anesthetic into the CNS. If convulsions occur, the patient's airway should be maintained, and supplemental oxygen administered. If seizure activity is sustained, 5-10 mg of diazepam should be administered slowly (1-2 mg/min) until the seizures cease.

Compared with the CNS, the cardiovascular system is less susceptible to the effects of local anesthetics. Most adverse effects of the cardiovascular system that occur with the administration of local anesthetics are a result of the addition of epinephrine rather than direct effects of the anesthetic. However, high blood levels of local anesthetics directly reduce cardiac contractility. In addition to the direct vasodilatory effects of most local anesthetics, the decrease in cardiac function can cause hypotension. Atrioventricular blocks, bradycardia, and ventricular arrhythmias also are reported; these are more common in patients with known conduction disturbances and requiring antiarrhythmic medications.

The treatment of conduction disturbances should be appropriately tailored to the type of reaction. The treatment of hypotension requires the physician to initiate advanced cardiac life support protocols, that is, he or she should ensure that the patient has a patent airway, provide supplemental oxygen, and elevate the patient's legs. If necessary, intravenous fluid should be administered, and the use of vasopressor agents such as ephedrine should be considered. Ephedrine can be intravenously administered in 5-mL incremental doses to a total of 15-30 mg, until a blood pressure response is noted.

Lidocaine and the FDA-approved topical anesthetics EMLA and LMX are pregnancy category B medications.

Allergic reactions

Allergic reactions to local anesthetics are extremely rare, especially with amide local anesthetics, and account for less than 1% of the reactions caused by local anesthetics. Reactions can be type 1 (ie, anaphylactic) or type 4 (ie, delayed-type hypersensitivity) reactions. These reactions are not dose related, but, rather, they are idiosyncratic. Skin prick and intradermal test results are negative in the vast majority of patients, but some authors recommend testing with the most commonly used amide local anesthetic (lidocaine).

Type 1 reactions are usually caused by ester-type anesthetics. The ester group of local anesthetics have a much greater allergenic potential than that of the amide group. Pseudocholinesterases, which produce the highly allergenic metabolic product PABA, break down ester-type anesthetics. Cross-reactivity exists among ester anesthetics; therefore, the use of

all anesthetics in this structural group should be avoided in a patient with an established sensitivity to one ester-type anesthetic.

No cross-reactivity appears to exist between ester and amide anesthetics; however, cross-reactivity in anaphylactic reactions has not been investigated thoroughly. In addition, reactions to preservatives, specifically methylparaben and sodium metabisulfate (found in multiple-dose vials of amide anesthetics), may cause adverse reactions in a patient who is allergic to an ester-type anesthetic. Preservative-free single-dose vials of lidocaine are available for use if an amide anesthetic is to be used in a patient with a true hypersensitivity reaction to ester-type anesthetics.

Clinical signs of type I reactions include pruritus, urticaria, facial swelling, wheezing, dyspnea, cyanosis, laryngeal edema, nausea, vomiting, and abdominal cramping. Epinephrine with a concentration of 1:1000 should be subcutaneously administered at a dose of 0.3-0.5 mL. This dose can be repeated every 20-30 minutes to a maximum of 3 doses. If anaphylaxis ensues, a 5-mL dose of epinephrine 1:10,000 should be administered intravenously.

Type IV (ie, delayed-type hypersensitivity) reactions account for 80% of allergic reactions to local anesthetics. They are more common with the use of topical anesthetics and may occur with anesthetics of the amide and ester subtypes. Clinical manifestations are similar to those of allergic contact dermatitis and include erythema, plaques, and pruritus. Patients with a history of type IV reactions are not at an increased risk of type I reactions due to amide-type anesthetics. Contact dermatitis caused by topical anesthetics should be treated with topical steroid preparations.

Alternative agents for use as anesthetics in patients with a known allergy to both ester- and amide-type local anesthetics include isotonic sodium chloride solution and injectable antihistamines. An intradermal injection of 0.9% sodium chloride solution can provide temporary anesthesia suitable for shave or punch biopsy. Physical pressure on the nerve endings resulting from the volume injected is postulated to be responsible for the anesthetic effect. Nonbacteriostatic sodium chloride solution should be used if the patient has an allergy to the methylparaben preservative in the local anesthetic. A bacteriostatic solution, which contains benzyl alcohol, has known anesthetic properties and can be used for limited procedures such as punch biopsy.

Injectable antihistamines, such as diphenhydramine, have been administered to patients who are allergic to local anesthetics. The mechanism of anesthetic action is unknown. Injectable diphenhydramine is effective, but it has a short duration of activity, it is sedating, and its injection is painful. In addition, tissue necrosis is reported after the local injection of 5% diphenhydramine. If used for injection, diphenhydramine should be diluted to 1% by mixing 1 vial of 50-mg diphenhydramine with 4 mL of a bacteriostatic sodium chloride solution.

Reactions to local anesthetic additives

Epinephrine

With the exception of cocaine, local anesthetics directly cause relaxation of the vascular smooth muscle, which leads to vasodilation. This effect increases bleeding at the surgical site. Vasoconstrictors, such as epinephrine, are often added to anesthetic solutions to counteract this effect. The vasoconstrictor effect of epinephrine is maximal at 7-15 minutes, and this effect is

clinically evident as blanching of the skin. This blanching also is useful in determining the area that is anesthetized.

Vasoconstriction not only decreases bleeding but also slows the rate of systemic absorption of the anesthetic, which allows the body more time to metabolize the anesthetic and prolongs anesthesia. Therefore, larger volumes of anesthetic can be injected when epinephrine is added to a solution. A premixed solution of lidocaine with epinephrine in a concentration of 1:100,000 (1 mg/100 mL) is available. Concentrations greater than this are associated with a higher rate of adverse effects, including an increased risk of tissue necrosis as a result of prolonged ischemia.

Systemic effects of epinephrine can occur with a dose as little as 2 mL of an anesthetic solution containing epinephrine in a concentration of 1:100,000. The most common clinical manifestation is transient tachycardia. At higher doses and with an inadvertent intravascular injection, palpitations, diaphoresis, angina, tremors, nervousness, and hypertension can occur. The maximum dose of epinephrine is 1 mg or 100 mL of a 1:100,000 solution. In patients with a history of heart disease, especially unstable angina and arrhythmias, the maximum dose should be decreased to 0.2 mg or 20 mL of a 1:100,000 solution (recommendation of the NY Heart Association).

Epinephrine is contraindicated in patients with pheochromocytoma, hyperthyroidism, severe hypertension, or severe peripheral vascular occlusive disease. Relative contraindications include pregnancy and psychological instability; epinephrine can induce an acute psychotic episode in predisposed patients.

The FDA designates epinephrine as a pregnancy category B medication (ie, usually safe but benefits must outweigh the risks). No known adverse effects on the fetus are reported; however, during the first trimester, vasoconstriction may cause fetoplacental ischemia and affect organogenesis. In the last trimester, epinephrine can induce premature labor if placental ischemia occurs. If possible, surgery should be performed without epinephrine, or it should be postponed until after delivery.

Epinephrine must be used with caution in patients taking propranolol because life-threatening reactions have been reported; these include hypertension, myocardial infarction, and stroke. Epinephrine stimulates alpha-receptors to cause vasoconstriction and increase vascular resistance. Beta-receptors balance this effect by causing vasodilation (beta2-receptors) and an increased heart rate (beta1-receptors). Like other nonselective beta-blockers, propranolol antagonizes both beta1-receptors and beta2-receptors. Therefore, in the presence of propranolol, the effects of epinephrine on alpha-receptors are unbalanced, and the result is pure alpha stimulation, which leads to severe hypertension and reflex bradycardia.

Although propranolol is the only nonselective beta-blocker reported to have this effect, probably all nonselective beta-blockers have the potential to cause severe hypertension and reflex bradycardia in the presence of epinephrine. A significant risk does not appear to be associated with the use of epinephrine and cardioselective beta-blockers. Although the use of epinephrine in patients who are taking nonselective beta-blockers is not contraindicated, it should be avoided if possible. Apparently, the effect may be dose related, and caution should be exercised because individual variability is reported.

In addition to nonselective beta-blockers, monoamine oxidase inhibitors, tricyclic antidepressants, butyrophenones, and phenothiazines can cause hypotension or hypertension in patients who are taking epinephrine.

Pain resulting from the infiltration of a local anesthetic can be reduced by using a solution with a pH close to physiologic range (ie, pH 7.3-7.4). The pH of plain lidocaine is 6.3-6.4. When epinephrine is added to lidocaine, the pH decreases to 3.5-4.5. The pH of the solution must be acidic to prevent the degradation of epinephrine.

Sodium bicarbonate

To reduce the pain of an injection of lidocaine and epinephrine, 1 mL of sodium bicarbonate 8.4% is added to 10 mL of the anesthetic solution to neutralize the solution. Buffered solutions should be discarded after 1 week because the effectiveness of epinephrine decreases by almost 25% during this time.

Hyaluronidase

Hyaluronidase is a bovine-derived enzyme that hydrolyzes hyaluronic acid in the connective tissue and facilitates the diffusion of the anesthetic. Although it can increase the spread of anesthesia, hyaluronidase also decreases the duration of action of the anesthetics because it increases absorption. As expected, this increased absorption leads to the potential for a greater incidence of toxic reactions that correspond to elevated blood levels. To decrease distortion of the surgical site, the addition of hyaluronidase is useful for nerve blocks and procedures around the orbit.

Hyaluronidase is marketed in ampules. One ampule is equivalent to 150 United States Pharmacopeia (USP) units per milliliter. The usual dilution is 150 U in 30 mL of anesthetic. A patient can have an allergy to hyaluronidase. Hyaluronidase is a foreign protein, and its use is contraindicated in patients with a known allergy to bee stings. In addition, hyaluronidase contains the preservative thimerosal, which is a known allergen. To evaluate the potential for an allergic reaction before infiltration, a test dose should be injected intradermally. If urticaria is observed at the site of the test injection, the use of hyaluronidase is contraindicated.

Future of Anesthetics

Tumescent anesthesia

In 1987, Jeffery Klein, a dermatologist, first created the technique of tumescent anesthesia in liposuction procedures.[1] Tumescent anesthesia is based on the use of dilute solutions of lidocaine (0.05-0.1%) in large volumes to provide superior anesthesia. Epinephrine (1:1,000,000) is added for hemostasis, and the solution is buffered with sodium bicarbonate to decrease injection discomfort. Concentrations as high as 55 mg/kg have been used safely with the tumescent technique.

The use of such high total doses of anesthetic without systemic toxicity is understood. The absorption kinetics of lidocaine change when high-volume, low-concentration solutions are used. Decreased concentrations of lidocaine also result in slower plasma absorption with decreased

peak plasma levels. The development of this anesthetic delivery system has revolutionized the surgical technique of liposuction

Anestesi lokal dan regional Penulis: Robyn Gmyrek, MD; Kepala Editor: Dirk M Elston, MD

PendahuluanAnestesi lokal memberikan rasa hilangnya suatu sensasi yang reversible. Anestesi lokal mengurangi rasa nyeri, karena itu, anestesi lokal sering dipakai sebaai suatu prosedur pada pembedahan. Teknik pemberian pada anestesi lokal bermacam – macam sehingga pemakaian anestesi lokal dapat dipakai secara luas. Teknik ini mencakup anestesi topical, anestesi infiltrative, blok ring, dan blok perifer.

Anestesi lokal lebih aman daripada anestesi umum sehingga dapat digunakan kapan pun bila dibutuhkan. Sebagai tambahan, anestesi lokal juga mudah untuk diberikan dan persediaannya juga cukup mudah didapat. Anestesi lokal telah dikembangkan selama bertahun – tahun, dan penelitian tentang anestesi lokal ini berlanjut secara terus menerus untuk memberi para ahli bedah variasi pengobatan dan memberikan agen anestesi yang lebih aman dan efektif kepada pasien

Latar BelakangWalaupun dunia medis tak bisa menyembuhkan semua penyakit, kontrol terhadap nyeri dan kenyamanan pasien adalah prioritas utama. Pada tahun 1860, kokain, yang merupakan anestesi tertua, di ekstrak pada daun yang bernama erthroxylon coca. Pada tahun 1884, Sigmund Freud dan Karl Koller lah yang pertama kali menggunakannya sebagai agen anestesi pada operasi oftalmologi

Prokain, suatu sintesis dari kokain mulai dikembangkan tahun 1904. Prokain adalah golongan ester yang merupakan turunan asam para-aminobenzoat(PABA). Setelah prokain di metabolisme, terdapat pelepasan alergen sebagai produk dari metabolisme. Pelepasan allergen ini menyebabkan reaksi alergi berat sehingga terdapat pembatasan pada pemakaian prokain dan agen anestesi golongan ester lainnya. Tetrakain, gologan ester lainnya mulai dikenalkan pada tahun 1930. Tetrakain lebih poten dari pada prokain tapi tetap menyebabkan reaksi alergi yang sama

Pada tahun 1943, Lofgern menemukan golongan anestesi lain yang bernama lidokain. Lidokain adalah golongan amide turunan dari asam diethylaminoacetic, bukan PABA, karena itu agen anestesi ini jarang menyebabkan alergi. Sejak saat itu, beberapa agen

anestesi golongan amide mulai diperkenalkan dan dipakai secara klinis. Modifikasi dari bahan – bahan kimia yang ada pada agen anestesi ini menghasilkan suatu keuntungan yang lebih, seperti peningkatan potensi dan durasi dari kerja anestesi. Perubahan ini memberikan ahli bedah lebih banyak pilihan, dan ahli anestesi pun dapat menyesuaikan agen anestesi sesuai dengan prosedur yang akan dilakukan

PatofisiologiSebelum mendiskusikan anestesi lokal, ada baiknya kita mereview tentang fisiologi konduksi saraf. Saraf mentransmisikan sensasi yang dihasilkan dari peningkatan jumlah impuls listrik. Peningkatan ini dicapai dengan merubah gradien ion yang ada di sepanjang dinding pembuluh saraf

Pada keadaan istirahat normal, saraf mempunyai potensial membran yang negatif, yaitu sebanyak -70mV. Potensial istirahat ini ditentukan oleh konsentrasi gradien 2 ion besar, yaitu Na dan K, dan permeabilitas dari membran terhadap ion – ion tersebut. Konsentrasi gradien di jaga oleh pompa sodium/potassium yang mentransport ion sodium keluar sel dan memasukan potassium kedalam sel. Oleh sebab itu, karena membran saraf bersifat permeable terhadap ion potassium dan tidak permeable terhadap ion sodium, 95% dari kebocoran ion pada sel yang tereksitasi disebabkan oleh fluktuasi luar yang dibentuk oleh ion K dan menyebabkan potensial membran menjadi negatif. Pada penelitian terakhir ditemukan kebocoran ion K yang terjadi oleh karena adanya 2-pore domain potassium

Ketika saraf terstimulasi, terjadi depolarisasi pada saraf, dan terbentuk proses peningkatan impuls. Awalnya, ion sodium masuk kedalam sel melalui membrane sel saraf. Masuknya ion sodium menyebabkan potensial istirahat meningkat menjadi potensial istrik transmembran. Ketika suatu potensial sudah mencapai suatu titik tertentu kira – kira -55mV, terjadi influx cepat pada ion sodium. Saluran sodium pada membran teraktivasi, dan permeabilitas sodium pun meningkat menyebabkan membrane saraf ter depolarisasi menjadi diatas +35mV

Setelah depolarisasi selesai, membran menjadi tak permeable terhadap sodium dan konduksi dari ion potasium ke dalam sel meningkat. Proses ini mengembalikan potasium intraseluler yang berlebihan dan sodium ekstraseluler dan mengembalikan potensial membran yang negatif. Perubahan dari potensial membran sel saraf dinamakan potensial aksi.

Mekanisme KerjaAnestesi lokal menghambat depolarisasi membrane saraf dengan mengganggu aliran Na

dan K sehingga potensial aksi tak akan terjadi karena titik tertentu yang dibutuhkan tak akan tercapai.

Walaupun mekanisme pasti dari lokal anestesi belum diketahui, terdapat 2 teori yang menggambarkannya. Teori ekspansi membran menyatakan anestesi lokal diabsorbsi ke dalam membran sel, memperluas membran dan mengakibatkan penyempitan saluran sodium. Hipotesis ini akhirnya tersingkirkan oleh teori reseptor. Teori reseptor ini menyebutkan bahwa anestesi lokal berdifusi ke seluruh membran sel dan terikat oleh reseptor – reseptor tertentu saat pembukaan gerbang saluran sodium. Afinitas anestesi lokal terhadap gerbang saluran natrium meningatkan rasio eksitasi neuron. Pengikatan ini mengakibatkan perubahan struktur atau fungsi dari saluran dan menghambat pergerakan ion sodium. Pemblokan aliran ion K oleh anestesi lokal dianggap dapat menyeabkan blok konduksi dengan mengurangi kemampuan dari saluran untuk mengeset potensial membran.

Dilihat dari diameternya, serabut saraf dikategorikan menjadi 3 tipe. Serabut tipe A merupakan serabut terbesar dan bertanggung jawab dalam konduksi dan sensasi motorik. Serabut tipe B berukuran sedang dan termyelinisasi. Serabut tipe C, berukuran kecil dan tak termyelinisasi bekerja mengahantarkan rasa sakit dan sensasi suhu. Karena ukurannya yang kecil, serabut saraf tipe C lebih mudah di blok disbanding serabut saraf tipe A. karena itu, pasien yang sensasi nyerinya di blok masih dapat merasakan tekanan dan mobilitas karena tidak terbloknya serabut saraf tipe A.

Semua anestesi lokal mempunyai struktur kimia yang sama, yaitu terdiri dari 3 komponen: Bagian aromatik, rantai intermediasi, dan grup amine. Bagian aromatik terbentuk dari benzenering yang bersifat lipofilik, sedangkan grup amine membuat anestesi lokal menjadi hidrofilik. Derajat kelarutan lipid pada tiap agen anestesi merupakan hal yang penting karena semakin larut agen anestesi maka difusi menuju membran saraf yang bersifat lipofilik akan semakin baik. Batas dari lipofillisitas agen anestesi berbanding lurus dengan potensi kerjanya.

Diagram Molekul.

Anestesi lokal membutuhkan garam hidroklorida agar dapat larut dalam air untuk diinjeksikan. Garam menyeimbangkan antara bentuk ion dan non ion pada suatu larutan.

Penyeimbangan sangat diperlukan karena walaupun bentuk yang terionisasi sudah dapat diinjeksi, bentuk yang tak terionisasi pun mempunyai peran dalam difusi menuju membran sel saraf. Durasi kerja dari obat anestesi dipengaruhi oleh protein yang mengikat agen anestesi tersebut, ini dikarenakan reseptor anestesi pada membran sel saraf adalah protein

Indikasi Anestesia ini digunakan untuk mengurangi nyeri sebelum proses operasi dimulai

KontraindikasiPasien menderita alergi oleh agen anestesi tertentu

AnestesiaAnestesi lokal diklasifikasikan menjadi 2 bagian: Golongan Ester dan golongan amide. Klasifikasi ini berdasarkan struktur kimia dari rantai intermediasi. Perbedaan struktur mempengaruhi jalur metabolisme dan potensi alergi

Golongan ester dimetabolisme dengan hidrolisis, yang dipengaruhi oleh enzim pseudokolinesterase di plasma. Pasien yang mempunyai kelainan genetik pada struktur enzim ini mengakibatkan pasien tak dapat memetabolisme anestesi golongan ester; ketidak mampuan untuk metabolisme ini memungkinkan pasien mendapat peningkatan

level serum anestesi pada darah dan menyebabkan reaksi toksik dalam tubuh. Sebagai tambahan, salah satu produk metabolisme yang muncul adalah PABA, yang dapat menghambat kerja sulfonamide dan merupakan alergen yang terkenal luas. Pada pasien dengan alergi anestesi golongan ester, penggunaan agen anestesi ini harus dihindari

Golongan amide di metabolisme oleh enzim mikrosomal yang terletak pada hepar. Enzim yang bertugas untuk mengeliminasi lidokain adalah cytochrome P-4503A4. Karena itu, anestesi tipe amide harus hati – hati diberikan pada pasien dengan gangguan hati berat dan pasien yang meminum obat yang dapat mengganggu metabolisme anestesi, pasien juga harus dimonitor tanda – tanda dari keracunan

Cytochrome P-4503A4 berada di hepar dan usus kecil. Obat – obat yang menghambat cytochromeP-4503A4 tedapat pada tabel di bawah. Inhibitor spesifik dari cytochrome P-4503A4 yang telah teruji secara klinis yaitu itrakonazol, ketokonazol, eritromisin, klaritomisin, siklosporin, amprenavir, indinavir, nelfinavir, ritonavir, diltiazem, mibefradil, dan nefazodon. Jus anggur juga merupakan inhibitor dari P-4503A4

Bila enzim ini terhambat karena pengaruh medikasi obat, enzim ini tak akan bisa memetabolisme agen anestesi dan berpotensi menaikan dosis menjadi dosis toksik. Sebagai tambahan, beta bloker dapat menurunkan aliran darah ke hepar; sehingga beta bloker juga dapat menurunkan metabolisme dari golongan amide dan membuat level serum agen anestesi dalam darah meningkat

Anesthetic

Duration Without Epinephrine,

min 

Duration With Epinephrine,

min 

Maximum Dose Without Epinephrine,

mg/kg 

Maximum Dose With Epinephrine,

mg/kg 

Esters

Cocaine 45 - 2.8 -

Procaine 15-30 30-90 7.1 8.5

Chloroprocaine

30-60 - 11.4 14.2

Tetracaine 120-240 240-480 1.4 -

Amides

Lidocaine 30-120 60-400 4.5 7

Mepivacaine 30-120 30-120 4.5 7

Bupivacaine 120-240 240-480 2.5 3.2

Etidocaine 200 240-360 4.2 5.7

Prilocaine 30-120 60-400 5.7 8.5

*Adapted from Dinehart.[2]

KomplikasiEfek lokalefek samping lokal biasanya terjadi akibat teknik penyuntikan. Efek samping yang muncul adalah nyeri, ekimosis, hematom, infeksi dan nyeri saraf. Nyeri akan selalu muncul pada saat anestesi lokal di injeksi; akan tetapi, nyeri tersebut dapat dikurangi dengan menggunakan teknik tertentu. Faktor – faktor seperti jarum, iritasi yang disebabkan oleh anestesi, dan distensi jaringan yang disebabkan infeksi merupakan hal yang membuat ketidaknyamanan pasien saat penggunaan anestesi lokal

Pasien anak dan pasien yang gelisah atau takut dapat diberi penanganan awal terlebih dahulu dengan anestesi topikal. Penanganan awal ini menghilangkan nyeri yang terjadi saat penyuntikan. Penyuntikan dengan jarum yang diameternya lebih kecil juga membantu mengurangi nyeri.

Iritasi jaringan yang disebabkan oleh anestesi lokal terkait dengan tingkat keasaman larutan yang akan disuntikan: karena itu, meningkatkan pH larutan akan mengurangi nyeri atau ketidaknyamanan pasien. Penambahan epinefrin pada larutan anestesi mengurangi pH larutan dan membuat larutan tersebut lebih asam dan mengakibatkan nyeri yang lebih hebat saat penyuntikan. pH larutan dapat dinetralisir dengan pemberian sodium bikarbonat 8,4% untuk meminimalisir nyeri. Sebagai contoh, bikarbonat 8,4% dapat ditambahkan ke lidokain dengan epinefrin dalam rasio 1:10 untuk mencapai pH yang sama dengan pH jaringan (pH 7,3 – 7,4)

Nyeri yang dikarenakan distensi jaringan disebabkan oleh rasio penyuntikan dan volume larutan yang diinjeksi. Untuk mengurangi rasa sakit, anestesi harus diberikan secara perlahan guna menambah waktu pada reseptor untuk menampung volume cairan yang baru. Karena itu lah volume larutan yang di injeksi harus menggunakan volume yang terkecil.

Penelitian menunjukan pasien yang mendapat injeksi subkutan atau intradermal dengan suhu larutan sama dengan suhu tubuh manusia membuat nyeri saat injeksi berkurang. Jika memungkinkan, menghangatkan semua larutan anestesi lokal harus dilakukan sebelum penyuntikan

Pembentukan ekimosis atau lokal hematoma adalah akibat dari perforasi pembuluh darah. Komplikasi ini sering ditemukan pada area yang mepunyai vaskularisasi tinggi, termasuk membran mukus, kepala, dan genitalia. Ekimosis dan hematoma akan lebih sering muncul saat pasien mempunyai kelainan perdarahan atau meminum obat aspirin atau antikoagulan lainnya. Jika terjadi ekimosis, berikan edukasi pada pasien. Bila hematoma muncul, evaluasi pasien.

Infeksi adalah komplikasi lokal yang terjadi karena teknik sterilisasi yang tidak baik. Membersihkan bagian kulit dengan alkohol wajib dilakukan. Bila tanda – tanda infeksi muncul, penatalaksanaan menggunakan antibiotik yang sesuai dengan kultur. Jika terjadi abses, drainase mungkin diperlukan

Laserasi saraf dapat terjadi karena infiltrasi dari anestesi lokal. Komplikasi ini umumnya terdapat saat melakukan blok regional. Gejala – gejala yang muncul yaitu parestesia, rasa tertusuk dan nyeri yang berlebih saat penyuntikan jarum. Parestesia nervus infraorbital dikarakteristikan dengan sensasi nyeri pada bibir bagian atas, hidung, dan gigi bagian atas

Bila jarum sudah dicurigai memasuki atau menusuk bagian saraf, jarum tersebut harus segera ditarik perlahan 1-2 mm sampai gejala parestesia menghilang. Jarum tak boleh dimasukan lebih dalam lagi karena meningkatkan resiko laserasi saraf.

Cedera tendon adalah aspek turunan digital anestesi karena jarum diinjeksi menuju tendon. Keadaan ini dapat menyebabkan gangguan 1 – 2 hari setelah pembedahan.

Efek samping kulit dilaporkan diakibatkan oleh penggunaan anestesi topikal dengan gejala – gejala gatal, rasa terbakar, nyeri, eritema, pucat, edema, purpura. Dermatitis kontak iritan, dermatitis kontak alergika jug adapt terjadi tapi jarang.

Amethocaine dapat menyebabkan reaksi urtikaria pada tempat penyuntikan.

SistemikEfek sistemik umumnya terjadi ketika konsentrasi anestesi lokal dalam derah mencapai level toksik. Pemebrian dosis dalam jumlah besar dapat memicu efek toksin ini. Penambahan vasokonstriktor dapat mengurangi absorpsi sistemik dari obat anestesi. Ketika menggunakan anestesi topikal, dianjurkan menggunakan tak lebih dari dosis maksimal, dan harus lebih diperhatikan karena absorbsi pada jaringan mukosa pada kulit lebih banyak.

Ingatlah bahwa (1) metabolisme golongan ester berkurang pada pasien dengan defisiensi pseudocholinesterase dan (2) metabolisme golongan amide pada pasien yang memakai obat penghambat cytochrome P-450 berkurang, sehingga potensi anestesi meningkat dan berpotensi menjadi toksin. Reaksi alergi tidak terkait dengan level serum obat anestesi tapi justru dapat terjadi pada dosis manapun

Dosis maksimal yang aman pada lidokain untuk lokal anestesi telah ditetapkan. Untu dewasa dosis maksimum adalah 4,5 mg/kgBB. Dapat diberikan juga 7mg/kgBB bila lidokain dilarutkan dengan perbandingan 1:100.000 epinefrin sebagai vasokonstriktor. Dosis anak – anak yang direkomendasikan 1,5 – 2,5 mg/kgBB dan 3-4 mg/kgBB ditambah dengan epinefrin

Toksisitas sistemik yang diakibatkan oleh kenaikan level serum anestesi pada darah merupakan manifestasi klinis dari efek samping sistem saraf pusat dan kardiovaskular. System saraf pusat dipengarhi oleh dosis. Semakin tinggi level serum lidokain, semakin berat efek pada sistem saraf pusat

Dokter yang menggunakan anestesi lokal harus berhati hati dengan tanda dan gejala dari toksisitas sistemik. Pada level serum dalam darah berkisar 1-5 mcg/ml, pasien akan mengeluh tinnitus, rasa melayang, diplopia. Ditambah lagi, pasien dapat mengeluh mual, muntah. Bila level serum dalam darah berkisar 5-8 mcg/ml, pasien akan mengeluh nystagmus, tremor, kaku otot. Pasien juga dapat menderita halusinasi. Pada level serum 8-12 mcg/ml, kejang fokal dapat terjadi; selanjutnya dapat mengakibatkan kejang tonik klonik. Depresi pernafasan umumnya terjadi pada level serum 20-25 mcg/ml dan akan berlanjut ke koma.

Bila tanda keracunan sistem saraf pusat terjadi, maka langkah – langkah yang harus dilakukan adalah mengurangi hipoksia dan asidosis karena keadaan ini dapat meningkatan toksisitas anestesi lokal pertahankan jalan nafas pasien dan berikan oksigen yang cukup. Bila karbondioksida dalam darah meningkat, protein pengikat lidokain pun akan menurun menyebabkan peningkatan level lidokain bebas dalam darah. Meningkatnya respirasi dan alkalosis respiratorik meningkatkan kemungkinan kejang dan menurunkan pengeluaran anestesi lokal pada susunan saraf pusat. Jika konvulsi terjadi, pertahankan jalan nafas dan oksigenisasi, bila kejang terus berlanjut berikan diazepam 5-10 mg

Dibandingkan dengan susunan saraf pusat, sistem kardiovaskular tidak rentan terhadap efek lokal anestesi. Banyak efek samping dari sistem kardiovaskular yang terjadi adalah dari hasil penambahan epinefrin dan bukan karena efek obat anestesi itu sendiri. Walaupun begitu, tingginya level serum darah dari anestesi lokal menyebabkan penurunan fungsi jantung lalu menyebabkan hipotensi, blok atrioventricular, bradikardi, dan ventricular aritmia.

Penatalaksanaan gangguan konduksi harus disesuaikan dengan tipe reaksinya. Penatalaksanaan bradikardia membutuhkan dokter untuk melakukan bantuan hidup dasar dengan memastikan jalan nafas terjaga dan oksigenasi yang cukup. Ephedrine dapat diberikan secara intravena sebanyak 5ml dosis bertahap hingga 15-30mg

Reaksi alergi Reaksi alergi pada anestesi lokal jarang terjadi, terutama pada golongan amide. Reaksi alergi dapat terjadi tipe 1 atau tipe 4. Reaksi ini tak bergantung pada dosis dan bias muncul pada dosis berapapun.

Reaksi tipe 1 umumnya disebabkan tipe ester. Golongan ester mempunyai potensi alergi yang lebih besar dibanding golongan amide. Ini disebabkan oleh pseudocholinesterase menghasilkan produk metabolism berupa para amino benzoic acid yang merupakan alergen kuat.

Tidak ada reaksi silang yang muncul antara golongan ester dan amide; tetapi, reaksi silang pada reaksi anafilaktik belum diteliti secara jauh. Sebagai tambahan, reaksi methylparaben dan sodium metabisulfate dapat menyebabkan efek samping pada pasien yang alergi golongan ester.

Tanda – tanda klinis reaksi tipe 1 adalah pruritus, urtikaria, pembengakakan pada wajah, mengi, dispone, sianosis. Epinefrin dengan konsentrasi 1:1000 diberikan secara subkutan dengan dosis 0,3 – 0,5 ml. dosis ini dapat diulang 20 – 30 menit dengan maksimum 3 dosis

Reaksi tipe 4 bertanggung jawab atas 80% dari reaksi alergi pada anestesi lokal. Manifestasi klinis sama dengan gejala – gejala dermatitis kontak alergika meliputi eritema, plak, dan pruritus. Pasien dengan riwayat reaksi tipe 4 tidak mempunyai peningkatan resiko reaksi tipe 1 karena golongan amide. Dermatitis kontak karena anestesi topikal dapat diatasi dengan pemberian steroid topikal

Agen alternative yang dapat digunakan pada pasien alergi dengan golongan ester dan amide adalah larutan isotonis sodium klorida dan antihistamin injeksi. Injeksi intradermal larutan sodium klorida 0,9% dapat memberikan anesthesia sementara yang cocok pada saat ingin melakukan biopsi.

Antihistamin injeksi seperti difenhidramin telah diberikan oleh pasien dengan alergi anestesi lokal. Injeksi ini efektif, tetapi durasinya pendek, sedative, dan nyeri pada saat penyuntikan. Untuk pemakaian injeksi, difenhidramin harus dilarutkan dengan campuran 50 mg difenhidramin ditmabah 4ml larutan sodium klorida

Efek penambahan obat lain pada anestesi lokalEPINEFRINDengan kokain sebagai pengecualian, anestesi lokal langsung menyebabkan relaksasi dari vaskularisasi otot polos, yang akan mengakibatkan vasodilatasi. Efek ini akan meningatkan perdarahan saat pembedahan. Vasokonstriksi seperti epinefrin umumnya ditambahkan untuk melawan kerja anestesi ini. Efek vasokonstriktor pada epinefrin berkisar maksimal 7 – 15 menit.

Vasokonstriksi tidak hanya mengurangi perdarahan tapi juga memperlambat absorbsi sistemik dari anestesi, yang akan membuat tubuh mempunyai banyak waktu untuk metabolisme obat anestesi dan memperlama kerja agen anestesi. Karena itu, volume anestesi yang digunakan dapat lebih besar ketika ditambah dengan epinefrin. Pemakaian

epinefrin dengan konsentrasi lebih dari 1:100,000 dapat menyebabkan efek samping yaitu terjadinya nekrosis karena iskemia yang berkepanjangan

Efek sistemik dari epinefrin dapat muncul dengan dosis 2mL dan dicampur dengan larutan anestesi denga konsentrasi 1:100,000. Manifestasi klinis yang umum terjadi adalah takikardia. Pada dosis yang lebih tinggi terdapat palpitasi, angina, tremor, diaporesis. Dosis maksimum dari epinefrin adalah 1mg atau 100ml dengan larutan 1:100,000. Pasien dengan riwayat jantung dosis maksimum dikurangi menjadi 0,2 mg atau 20mL dalam larutan 1:100,000

Kontraindikasi epinefrin adalah pasien dengan pheochromocytoma, hipertiroid, hipertensi berat, kehamilan.

FDA mengkategorikan epinefrin sebagai obat kategori B. Belum ada penelitian efek pada fetus, tetapi pada trimester pertama, vasokonstriksi menyebabkan iskemik fetoplacental dan mempengaruhi organogenesis. Pada trimester akhir, epinefrin dapat menyebabkan lahir premature bila terdapat iskemia plasental.

Epinefrin harus digunakan dengan hati – hati pada pasien yang meminum propranolol karena terdapat reaksi yang membahayakan seperti miokard infark, stroke, dan hipertensi. Epinefrin menstimulasi reseptor alfa untuk memicu vasokonstriksi dan meningkatkan resistensi vaskular. Reseptor beta menyeimbangkan efek ini dengan membuat vasodilatasi dan meningkatkan denyut nadi. Propanolol merupakan antagonis dari reseptor beta 1 dan beta 2. Dengan demikian, pemberian propranolol menyebabkan efek epinefrin menjadi tidak seimbang sehingga menyebabkan hipertensi berat dan bradikardia.

Sodium bikarbonatUntuk mengurangi nyeri injeksi dari lidokain dan epinefrin, 1ml sodium bikarbonat 8.4% ditambahkan pada 10 ml larutan anestesi untu menetralisir pH larutan

HyaluronidaseHyaluronidase adalah enzim turunan bovine yang menghidrolisis asam hyaluronad di jaringan ikat dan memfasilitasi difusi pada agen anestesi. Walaupun hyaluronidase dapat meningkatkan penyebaran anestesia, enzim ini dapat menurunkan durasi dari obat anestesi karena dapat meningkatkan absorbs agen anestesi

Tumescent anesthesia

Pada tahun 1987, Jeffery Klein, seorang dermatologis menciptakan teknik tumescent anesthesia pada prosedur penyedotan lemak. Tumescent anesthesia didasari penggunaan larutan lidokain yang diencerkan (0,05 – 0,1%) dalam volume yang besar unurk memberikan efek anestesi yang lebih besar. Epinefrin ditambahkan untuk hemostasis, dan

larutan diberi sodium bikarbonat untuk mengurangi nyeri saat penyuntikan. Konsentrasi yang diberikan ialah 55mg/kgBB